(Q34572836)

3 August 2017

1 reference

title

Proliferative vitreoretinopathy: risk factors and pathobiology (English)

1 reference

proliferative vitreoretinopathy

3 August 2017

main subject

1 reference

J Carlos Pastor

1

1 reference

3 August 2017

E Rodríguez de la Rúa

series ordinal

2

1 reference

3 August 2017

Francisco Martín

series ordinal

3

1 reference

3 August 2017

publication date

1 January 2002

1 reference

Progress in Retinal and Eye Research

3 August 2017

published in

1 reference

3 August 2017

volume

21

1 reference

3 August 2017

issue

1

1 reference

3 August 2017

page(s)

127-144

1 reference

Factors influencing anatomic and visual results in primary scleral buckling

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

How to predict proliferative vitreoretinopathy: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy : Results from a randomized, double-blind, controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Immunocytology of cellular components in vitreous and subretinal fluid from patients with proliferative vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

The development of severe proliferative vitreoretinopathy after retinal detachment surgery. Grade B: a determining risk factor

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Cryopexy in primary rhegmatogenous retinal detachment: a risk factor for postoperative proliferative vitreoretinopathy?

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Autoimmune responsiveness to retinal IRBP, S-antigen and opsin in proliferative vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Comparative study of incomplete posterior vitreous detachment as a risk factor for proliferative vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Platelet derived growth factor and fibroblast growth factor basic levels in the vitreous of patients with vitreoretinal disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Proliferative vitreoretinopathy: pathobiology, surgical management, and adjunctive treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Growth factors in proliferative vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Proliferative vitreoretinopathy. Lymphocytes in epiretinal membranes

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Inflammatory cells in proliferative vitreoretinopathy subretinal membranes

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Comparison of flow cytometry with the surgeon regarding ability to predict the ultimate success of surgery for proliferative vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Clinical risk factors for proliferative vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Preoperative vitreous hemorrhage associated with rhegmatogenous retinal detachment: a risk factor for postoperative proliferative vitreoretinopathy?

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Intravitreal invading cells contribute to vitreal cytokine milieu in proliferative vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Macrophages in proliferative vitreoretinopathy and proliferative diabetic retinopathy: differentiation of subpopulations

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Pseudophakic retinal detachment: anatomic and visual results

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Clinical risk factors for proliferative vitreoretinopathy after retinal detachment surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Proliferative vitreoretinopathy. The mechanism of development of vitreoretinal traction

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Hepatocyte growth factor/scatter factor in the eye

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Origin of fibronectin in epiretinal membranes of proliferative vitreoretinopathy and proliferative diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

A multivariate analysis of anatomic success of retinal detachments treated with scleral buckling.

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Retinal and epiretinal glia--an immunohistochemical study.

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Thrombospondin as a component of the extracellular matrix of epiretinal membranes: Comparisons with cellular fibronectin

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Local production of fibronectin by ectopic human retinal cells

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Matrix and the retinal pigment epithelium in proliferative retinal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Prevention of experimental proliferative vitreoretinopathy with daunomycin and triamcinolone based on the time course of the disease

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Proliferative vitreoretinopathy membranes. An immunohistochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Risk factors for proliferative vitreoretinopathy after primary vitrectomy: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Glial cell proliferation in retinal detachment (massive periretinal proliferation)

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Epitheliomesenchymal transdifferentiation of cultured RPE cells

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Subretinal membranes in proliferative vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Vitreous levels of intercellular adhesion molecule 1 (ICAM-1) as a risk indicator of proliferative vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Surgical approaches to subretinal strands

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

An updated classification of retinal detachment with proliferative vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Migration of retinal microglia in experimental proliferative vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Onset and recurrence of proliferative vitreoretinopathy in various vitreoretinal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Fungal endophthalmitis after a single intravenous administration of presumably contaminated dextrose infusion fluid

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Risk factors for proliferative vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Immunohistochemical study of cellular fibronectin in preretinal membranes

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Retinal pigment epithelial cell proliferation: potentiation by monocytes and serum

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Retinal pigment epithelium cells promote the maturation of monocytes to macrophages in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Proliferative vitreoretinopathy: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Combined pharmacologic therapy in a rabbit model of proliferative vitreoretinopathy (PVR)

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

[Myofibroblasts and retinal fibrovascular membranes]

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Primary vitrectomy for rhegmatogenous retinal detachment: an analysis of failure.

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Traction retinal detachment. XLIX Edward Jackson Memorial Lecture

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

[Inhibition of proliferation of retinal pigment epithelium in vitro: vitamin A pharmacodynamics I]

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Proliferative vitreoretinopathy: a natural history of the fellow eye.

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

1 reference

7 January 2021

Matrix metalloproteinase biology applied to vitreoretinal disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Influence of pigment content, intracellular calcium and cyclic AMP on the ability of human retinal pigment epithelial cells to contract collagen gels

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Cloning and expression of murine SC1, a gene product homologous to SPARC.

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Immunostaining of preretinal membranes for actin, fibronectin, and glial fibrillary acidic protein

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Transforming growth factor-beta1 induces alpha-smooth muscle actin expression and fibronectin synthesis in cultured human retinal pigment epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Immunohistochemistry of anterior proliferative vitreoretinopathy. Report of 11 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Subretinal "napkin-ring" membrane in proliferative vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

The classification of retinal detachment with proliferative vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Morphological and pathogenetic aspects of proliferative vitreo-retinopathy. A histological and immunohistochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Proliferative retinal diseases: myofibroblasts cause chronic vitreoretinal traction

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Subretinal Fibrosis in Retinal Detachment

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Proliferative vitreoretinopathy--is it anything more than wound healing at the wrong place?

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Growth factors in retinal diseases: proliferative vitreoretinopathy, proliferative diabetic retinopathy, and retinal degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Wendell L. Hughes Lecture. Wound healing.

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Measurement of cellular proliferation within the vitreous during experimental proliferative vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Genistein produces reduction in growth and induces apoptosis of rat RPE-J cells

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

Induction of interleukin-8 in human retinal pigment epithelial cells after denuding injury

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2801%2900023-4

7 January 2021

10.1016/S1350-9462(01)00023-4

Identifiers

DOI

1 reference

3 August 2017

1 reference